Trumpism Lives on in Healthcare
The elections may be over, and the current administration is likely on its way out, but the core ideals of ...
Success In The Age of COVID-19
Hope springs eternal as we transition into a new administration with a new, and hopefully more scientific approach to the ...
Gaming Therapy
DEA Agents Martin and Jennings find themselves in the middle of another physician investigation, analyzing data to determine what they ...
A Framework For Medical Jurisprudence
Underlying all the political rancor of late is a pending matter that will have monumental implications on healthcare. The Supreme ...
The Heuristics In Our Medical Decisions
The study of medical decision-making is woefully underdeveloped relative to other fields of decision-making, such as quantitative finance and criminal ...
Trust Is Inherent To Healthcare
Trust is an essential aspect of healthcare - and without trust, healthcare breaks down into a series of facts, data ...
There Is A Doctor On The Ballot
To celebrate Election Day, Daily Remedy unveils a short story about a physician entering the world of politics. Dr. Kapoor, ...
Narratives – The Future of Healthcare
In today's healthcare, technology and data reign supreme. But as we move forward, first through and then beyond the COVID-19 ...
Predicting the Election by Anticipating Voter Behavior
The election is only days away and the uncertainty has never been greater. Politics has never been as polarizing and ...
Virtue In Healthcare
Healthcare is founded on the principles of virtue. In the Oath of Hippocrates, healthcare is defined as an art to ...
Perception & Corruption – Healthcare in Today’s Prisons
One of the hallmarks of modern healthcare is the emphasis on documentation. But anything that is emphasized is inevitably over-emphasized ...
Impending Militarization of COVID-19
The COVID-19 vaccine is now only weeks away from being available. But having a vaccine ready and having access are ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more